Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00082407
Status:
COMPLETED
Last Update Posted:
2015-04-07
First Post:
2004-05-06
Brief Title:
Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-11
Start Date Type:
None
Primary Completion Date:
2008-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-07
Completion Date Type:
ACTUAL
First Submit Date:
2004-05-06
First Submit QC Date:
May 7 2004
Study First Post Date:
2004-05-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2013-07-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-19
Last Update Post Date:
2015-04-07
Last Update Post Date Type:
ESTIMATED